Exp Ther Med 11: 49-56, 2016; DOI: 10.3892/etm.2015 DOI: 10.3892/etm. .2860 Subsequently to the publication of the above article, an interested reader drew to our attention that the article describes the use of the drug acetazolamide for IgA nephropathy on a number of occasions in the text, whereas the references refer to the drug azathioprine. The authors have confirmed that, owing to an oversight on their part, all the references to "acetazolamide" in their paper (abbreviated as 'AZA') should have been written as "azathioprine" (first, in the Abstract on p. 49, line 18, and suhsequently in the legends of Table I and Figs. 2 and 7) . Furthermore, the abbreviation for leflunomide should have been written throughout the paper as "LEF", not as "LET".
